Drug addiction and stress-response genetic variability: Association study in African Americans

Annals of Human Genetics

Volumn 78, Issue 4, 2014, Pages 290-298

  Levran, Orna ^a   Randesi, Matthew ^a   Li, Yi ^b   Rotrosen, John ^c   Ott, Jurg ^a,d   Adelson, Miriam ^a,e   Jeanne Kreek, Mary ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b SHANXI UNIVERSITY OF FINANCE AND ECONOMICS   (China)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d INSTITUTE OF PSYCHOLOGY   (China)

^e Dr Miriam and Sheldon G Adelson Clinic for Drug Abuse Treatment and Research   (United States)

Author keywords

African Americans; AVP; Cocaine addiction; FKBP5; GALR1; Heroin addiction; HPA axis; NR3C2; OXTR; Stress

Indexed keywords

GALANIN RECEPTOR 1; OXYTOCIN RECEPTOR;

ADULT; AFRICAN AMERICAN; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; CRHBP GENE; FEMALE; FKBP5 GENE; GALR1 GENE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEROIN DEPENDENCE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; NR3C2 GENE; PRIORITY JOURNAL; RECEPTOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM; STRESS; BIOLOGY; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; MENTAL STRESS; PHYSIOLOGICAL STRESS; SUBSTANCE-RELATED DISORDERS;

AFRICAN AMERICANS; CASE-CONTROL STUDIES; COMPUTATIONAL BIOLOGY; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; STRESS, PHYSIOLOGICAL; STRESS, PSYCHOLOGICAL; SUBSTANCE-RELATED DISORDERS;

EID: 84902657378     PISSN: 00034800     EISSN: 14691809     Source Type: Journal    
DOI: 10.1111/ahg.12064     Document Type: Article

References (55)

1. Appel, K., Schwahn, C., Mahler, J., Schulz, A., Spitzer, C., Fenske, K., Stender, J., Barnow, S., John, U., Teumer, A., Biffar, R., Nauck, M., Volzke, H., Freyberger, H. J. & Grabe, H. J. (2011) Moderation of adult depression by a polymorphism in the FKBP5 gene and childhood physical abuse in the general population. Neuropsychopharmacology 36, 1982-1991.
2. Badiani, A., Belin, D., Epstein, D., Calu, D. & Shaham, Y. (2011) Opiate versus psychostimulant addiction: The differences do matter. Nat Rev Neurosci 12, 685-700.
3. Barrett, J. C., Fry, B., Maller, J. & Daly, M. J. (2005) Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265.
4. Beer, B., Erb, R., Pavlic, M., Ulmer, H., Giacomuzzi, S., Riemer, Y. & Oberacher, H. (2013) Association of polymorphisms in pharmacogenetic candidate genes (OPRD1, GAL, ABCB1, OPRM1) with opioid dependence in European population: A case-control study. PLoS One 8, e75359.
5. Belfer, I., Hipp, H., McKnight, C., Evans, C., Buzas, B., Bollettino, A., Albaugh, B., Virkkunen, M., Yuan, Q., Max, M. B., Goldman, D. & Enoch, M. A. (2006) Association of galanin haplotypes with alcoholism and anxiety in two ethnically distinct populations. Mol Psychiatry 11, 301-311.
6. Bevilacqua, L., Carli, V., Sarchiapone, M., George, D. K., Goldman, D., Roy, A. & Enoch, M. A. (2012) Interaction between FKBP5 and childhood trauma and risk of aggressive behavior. Arch Gen Psychiatry 69, 62-70.
7. Binder, E. B., Salyakina, D., Lichtner, P., Wochnik, G. M., Ising, M., Putz, B., Papiol, S., Seaman, S., Lucae, S., Kohli, M. A., Nickel, T., Kunzel, H. E., Fuchs, B., Majer, M., Pfennig, A., Kern, N., Brunner, J., Modell, S., Baghai, T., Deiml, T., Zill, P., Bondy, B., Rupprecht, R., Messer, T., Kohnlein, O., Dabitz, H., Bruckl, T., Muller, N., Pfister, H., Lieb, R., Mueller, J. C., Lohmussaar, E., Strom, T. M., Bettecken, T., Meitinger, T., Uhr, M., Rein, T., Holsboer, F. & Muller-Myhsok, B. (2004) Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet 36, 1319-1325.
8. Binder, E. B., Bradley, R. G., Liu, W., Epstein, M. P., Deveau, T. C., Mercer, K. B., Tang, Y., Gillespie, C. F., Heim, C. M., Nemeroff, C. B., Schwartz, A. C., Cubells, J. F. & Ressler, K. J. (2008) Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 299, 1291-1305.
9. Claes, S., Villafuerte, S., Forsgren, T., Sluijs, S., Del-Favero, J., Adolfsson, R. & Van Broeckhoven, C. (2003) The corticotropin-releasing hormone binding protein is associated with major depression in a population from Northern Sweden. Biol Psychiatry 54, 867-872.
10. De Luca, V., Tharmalingam, S., Zai, C., Potapova, N., Strauss, J., Vincent, J. & Kennedy, J. L. (2010) Association of HPA axis genes with suicidal behaviour in schizophrenia. J Psychopharmacol 24, 677-682.
11. Ducci, F., Roy, A., Shen, P. H., Yuan, Q., Yuan, N. P., Hodgkinson, C. A., Goldman, L. R. & Goldman, D. (2009) Association of substance use disorders with childhood trauma but not African genetic heritage in an African American cohort. Am J Psychiatry 166, 1031-1040.
12. Enoch, M. A. (2011) The role of early life stress as a predictor for alcohol and drug dependence. Psychopharmacology (Berl) 214, 17-31.
13. Enoch, M. A., Shen, P. H., Ducci, F., Yuan, Q., Liu, J., White, K. V., Albaugh, B., Hodgkinson, C. A. & Goldman, D. (2008) Common genetic origins for EEG, alcoholism and anxiety: The role of CRH-BP. PLoS One 3, e3620.
14. Gold, A. B., Wileyto, E. P., Lori, A., Conti, D., Cubells, J. F. & Lerman, C. (2012) Pharmacogenetic association of the galanin receptor (GALR1) SNP rs2717162 with smoking cessation. Neuropsychopharmacology 37, 1683-1688.
15. Hodgkinson, C. A., Yuan, Q., Xu, K., Shen, P. H., Heinz, E., Lobos, E. A., Binder, E. B., Cubells, J., Ehlers, C. L., Gelernter, J., Mann, J., Riley, B., Roy, A., Tabakoff, B., Todd, R. D., Zhou, Z. & Goldman, D. (2008) Addictions biology: Haplotype-based analysis for 130 candidate genes on a single array. Alcohol Alcohol 43, 505-515.
16. Ishitobi, Y., Nakayama, S., Yamaguchi, K., Kanehisa, M., Higuma, H., Maruyama, Y., Ninomiya, T., Okamoto, S., Tanaka, Y., Tsuru, J., Hanada, H., Isogawa, K. & Akiyoshi, J. (2012) Association of CRHR1 and CRHR2 with major depressive disorder and panic disorder in a Japanese population. Am J Med Genet B Neuropsychiatr Genet 159B, 429-436.
17. Kellogg, S. H., McHugh, P. F., Bell, K., Schluger, J. H., Schluger, R. P., LaForge, K. S., Ho, A. & Kreek, M. J. (2003) The Kreek-McHugh-Schluger-Kellogg scale: A new, rapid method for quantifying substance abuse and its possible applications. Drug Alcohol Depend 69, 137-150.
18. Kendler, K. S., Jacobson, K. C., Prescott, C. A. & Neale, M. C. (2003) Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins. Am J Psychiatry 160, 687-695.
19. Klengel, T., Mehta, D., Anacker, C., Rex-Haffner, M., Pruessner, J. C., Pariante, C. M., Pace, T. W., Mercer, K. B., Mayberg, H. S., Bradley, B., Nemeroff, C. B., Holsboer, F., Heim, C. M., Ressler, K. J., Rein, T. & Binder, E. B. (2013) Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci 16, 33-41.
20. Koefoed, P., Woldbye, D. P., Hansen, T. O., Hansen, E. S., Knudsen, G. M., Bolwig, T. G. & Rehfeld, J. F. (2010) Gene variations in the cholecystokinin system in patients with panic disorder. Psychiatr Genet 20, 59-64.
21. Koob, G. & Kreek, M. J. (2007) Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry 164, 1149-1159.
22. Koob, G. F., Buck, C. L., Cohen, A., Edwards, S., Park, P. E., Schlosburg, J. E., Schmeichel, B., Vendruscolo, L. F., Wade, C. L., Whitfield, T. W., Jr. & George, O. (2014) Addiction as a stress surfeit disorder. Neuropharmacology. 76, 370-382
23. Kranzler, H. R., Feinn, R., Nelson, E. C., Covault, J., Anton, R. F., Farrer, L. & Gelernter, J. (2011) A CRHR1 haplotype moderates the effect of adverse childhood experiences on lifetime risk of major depressive episode in African-American women. Am J Med Genet B Neuropsychiatr Genet 156B, 960-968.
24. Kreek, M. J. & Koob, G. F. (1998) Drug dependence: Stress and dysregulation of brain reward pathways. Drug Alcohol Depend 51, 23-47.
25. Kreek, M. J., Nielsen, D. A., Butelman, E. R. & LaForge, K. S. (2005) Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nat Neurosci 8, 1450-1457.
26. Kreek, M. J., Levran, O., Reed, B., Schlussman, S. D., Zhou, Y. & Butelman, E. R. (2012) Opiate addiction and cocaine addiction: Underlying molecular neurobiology and genetics. J Clin Invest 122, 3387-3393.
27. Levran, O., Londono, D., O'Hara, K., Nielsen, D. A., Peles, E., Rotrosen, J., Casadonte, P., Linzy, S., Randesi, M., Ott, J., Adelson, M. & Kreek, M. J. (2008) Genetic susceptibility to heroin addiction: A candidate gene association study. Genes Brain Behav 7, 720-729.
28. Levran, O., Londono, D., O'Hara, K., Randesi, M., Rotrosen, J., Casadonte, P., Linzy, S., Ott, J., Adelson, M. & Kreek, M. J. (2009) Heroin addiction in African Americans: A hypothesis-driven association study. Genes Brain Behav 8, 531-540.
29. Levran, O., Peles, E., Randesi, M., Li, Y., Rotrosen, J., Ott, J., Adelson, M. & Kreek, M. J. (2014) Stress-related genes and heroin addiction: A role for a functional FKBP5 haplotype. Psychoneuroendocrinology, in press.
30. Lori, A., Tang, Y., O'Malley, S., Picciotto, M. R., Wu, R., Conneely, K. N. & Cubells, J. F. (2011) The galanin receptor 1 gene associates with tobacco craving in smokers seeking cessation treatment. Neuropsychopharmacology 36, 1412-1420.
31. Maher, B. S., Vladimirov, V. I., Latendresse, S. J., Thiselton, D. L., McNamee, R., Kang, M., Bigdeli, T. B., Chen, X., Riley, B. P., Hettema, J. M., Chilcoat, H., Heidbreder, C., Muglia, P., Murrelle, E. L., Dick, D. M., Aliev, F., Agrawal, A., Edenberg, H. J., Kramer, J., Nurnberger, J., Tischfield, J. A., Devlin, B., Ferrell, R. E., Kirillova, G. P., Tarter, R. E., Kendler, K. S. & Vanyukov, M. M. (2011) The AVPR1A gene and substance use disorders: Association, replication, and functional evidence. Biol Psychiatry 70, 519-527.
32. Maron, E., Nikopensius, T., Koks, S., Altmae, S., Heinaste, E., Vabrit, K., Tammekivi, V., Hallast, P., Koido, K., Kurg, A., Metspalu, A., Vasar, E., Vasar, V. & Shlik, J. (2005) Association study of 90 candidate gene polymorphisms in panic disorder. Psychiatr Genet 15, 17-24.
33. McLellan, A. T., Kushner, H., Metzger, D., Peters, R., Smith, I., Grissom, G., Pettinati, H. & Argeriou, M. (1992) The fifth edition of the addiction severity index. J Subst Abuse Treat 9, 199-213.
34. Montag, C., Brockmann, E. M., Bayerl, M., Rujescu, D., Muller, D. J. & Gallinat, J. (2013) Oxytocin and oxytocin receptor gene polymorphisms and risk for schizophrenia: A case-control study. World J Biol Psychiatry 14, 500-508.
35. Okahisa, Y., Ujike, H., Kotaka, T., Morita, Y., Kodama, M., Inada, T., Yamada, M., Iwata, N., Iyo, M., Sora, I., Ozaki, N. & Kuroda, S. (2009) Association between neuropeptide Y gene and its receptor Y1 gene and methamphetamine dependence. Psychiatry Clin Neurosci 63, 417-422.
36. Peters, J., Pattij, T. & De Vries, T. J. (2013) Targeting cocaine versus heroin memories: Divergent roles within ventromedial prefrontal cortex. Trends Pharmacol Sci 34, 689-695.
37. Picciotto, M. R. (2010) Galanin and addiction. EXS 102, 195-208.
38. Picciotto, M. R., Brabant, C., Einstein, E. B., Kamens, H. M. & Neugebauer, N. M. (2010) Effects of galanin on monoaminergic systems and HPA axis: Potential mechanisms underlying the effects of galanin on addiction- and stress-related behaviors. Brain Res 1314, 206-218.
39. Pritchard, J. K., Stephens, M. & Donnelly, P. (2000) Inference of population structure using multilocus genotype data. Genetics 155, 945-959.
40. Proudnikov, D., Hamon, S., Ott, J. & Kreek, M. J. (2008) Association of polymorphisms in the melanocortin receptor type 2 (MC2R, ACTH receptor) gene with heroin addiction. Neurosci Lett 435, 234-239.
41. Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A., Bender, D., Maller, J., Sklar, P., de Bakker, P. I., Daly, M. J. & Sham, P. C. (2007) PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81, 559-575.
42. Ray, L. A. (2011) Stress-induced and cue-induced craving for alcohol in heavy drinkers: Preliminary evidence of genetic moderation by the OPRM1 and CRH-BP genes. Alcohol Clin Exp Res 35, 166-174.
43. Ray, L. A., Sehl, M., Bujarski, S., Hutchison, K., Blaine, S. & Enoch, M. A. (2013) The CRHR1 gene, trauma exposure, and alcoholism risk: A test of G x E effects. Genes Brain Behav 12, 361-369.
44. Roy, A., Gorodetsky, E., Yuan, Q., Goldman, D. & Enoch, M. A. (2010) Interaction of FKBP5, a stress-related gene, with childhood trauma increases the risk for attempting suicide. Neuropsychopharmacology 35, 1674-1683.
45. Roy, A., Hodgkinson, C. A., Deluca, V., Goldman, D. & Enoch, M. A. (2012) Two HPA axis genes, CRHBP and FKBP5, interact with childhood trauma to increase the risk for suicidal behavior. J Psychiatr Res 46, 72-79.
46. Sinha, R. (2008) Chronic stress, drug use, and vulnerability to addiction. Ann N Y Acad Sci 1141, 105-130.
47. Sinha, R., Garcia, M., Paliwal, P., Kreek, M. J. & Rounsaville, B. J. (2006) Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes. Arch Gen Psychiatry 63, 324-331.
48. Stankova, T., Eichhammer, P., Langguth, B. & Sand, P. G. (2012) Sexually dimorphic effects of oxytocin receptor gene (OXTR) variants on harm avoidance. Biol Sex Differ 3, 17.
49. Tsuang, M. T., Lyons, M. J., Meyer, J. M., Doyle, T., Eisen, S. A., Goldberg, J., True, W., Lin, N., Toomey, R. & Eaves, L. (1998) Co-occurrence of abuse of different drugs in men: The role of drug-specific and shared vulnerabilities. Arch Gen Psychiatry 55, 967-972.
50. Vanyukov, M. M., Tarter, R. E., Kirisci, L., Kirillova, G. P., Maher, B. S. & Clark, D. B. (2003) Liability to substance use disorders: 1. Common mechanisms and manifestations. Neurosci Biobehav Rev 27, 507-515.
51. Wei, J., Chu, C., Wang, Y., Yang, Y., Wang, Q., Li, T., Zhang, L. & Ma, X. (2012) Association study of 45 candidate genes in nicotine dependence in Han Chinese. Addict Behav 37, 622-626.
52. Wetherill, L., Schuckit, M. A., Hesselbrock, V., Xuei, X., Liang, T., Dick, D. M., Kramer, J., Nurnberger, J. I., Jr., Tischfield, J. A., Porjesz, B., Edenberg, H. J. & Foroud, T. (2008) Neuropeptide Y receptor genes are associated with alcohol dependence, alcohol withdrawal phenotypes, and cocaine dependence. Alcohol Clin Exp Res 32, 2031-2040.
53. Xie, P., Kranzler, H. R., Poling, J., Stein, M. B., Anton, R. F., Farrer, L. A. & Gelernter, J. (2010) Interaction of FKBP5 with childhood adversity on risk for post-traumatic stress disorder. Neuropsychopharmacology 35, 1684-1692.
54. Zhao, X., Seese, R. R., Yun, K., Peng, T. & Wang, Z. (2013) The role of galanin system in modulating depression, anxiety, and addiction-like behaviors after chronic restraint stress. Neuroscience 246, 82-93.
55. Zimmermann, P., Bruckl, T., Nocon, A., Pfister, H., Binder, E. B., Uhr, M., Lieb, R., Moffitt, T. E., Caspi, A., Holsboer, F. & Ising, M. (2011) Interaction of FKBP5 gene variants and adverse life events in predicting depression onset: Results from a 10-year prospective community study. Am J Psychiatry 168, 1107-1116.